(Q48622786)

English

Anti-Müllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments

scientific article published in July 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Anti-Müllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

author name string

Alon Kedem

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Ariel Hourvitz

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Yuval Yung

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Libby Shalev

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Gil M Yerushalmi

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Hannah Kanety

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Mirit Hanochi

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Ettie Maman

8

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

publication date

1 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

29

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

651-656

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone remains highly expressed in human cumulus cells during the final stages of folliculogenesis

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

PCOS and peripheral AMH levels in relation to FSH receptor gene single nucleotide polymorphisms.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Viable embryos from injection of round spermatids into oocytes

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

High expression of luteinizing hormone receptors messenger RNA by human cumulus granulosa cells is in correlation with decreased fertilization

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Concentration of anti-Müllerian hormone and inhibin-B in relation to steroids and age in follicular fluid from small antral human follicles

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Polycystic ovary syndrome and its developmental origins.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.798279

21 January 2018

Identifiers

10.3109/09513590.2013.798279

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/23772776

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48622786&oldid=2203506503"